For example, in a patient with glioblastoma, tumor-normal match pair WES identified a germline variant RUNX1-M151L deemed likely pathogenic (ACMG guidelines [34]) but not reported with tumor-only NGS (Caris Life Sciences) as it was not included in their panel. This evidence concerns the gene RUNX1 and neoplasm.